CARA
Cara Therapeutics Inc
Price:  
0.27 
USD
Volume:  
313,148.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA Fair Value

-3,294.95 %
Upside

As of 2024-12-11, the Fair Value of Cara Therapeutics Inc (CARA) is -8.71 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 USD, the upside of Cara Therapeutics Inc is -3,294.95%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.27 USD
Stock Price
-8.71 USD
Fair Price
FAIR VALUE CALCULATION

CARA Fair Value

Peter Lynch's formula is:

CARA Fair Value
= Earnings Growth Rate x TTM EPS
CARA Fair Value
= 5.00 x -1.74
CARA Fair Value
= -8.71

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -106.40 8.40 -88.40 -85.50 -118.51 -78.08
YoY growth -43.78% 107.89% -1,152.38% 3.28% -38.61% -224.72%

CARA Fair Value - Key Data

Market Cap (mil) 14.95
P/E
Forward P/E
EPS -1.74
Avg earnings growth rate -224.72%
TTM earnings -95.53